Multiple Sclerosis: all 3,524 studies
Page 36 of 36. Open to participants first (668), then studies with results posted, then the rest; newest registration first within each.
- High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple SclerosisCompletedNCT00040482Phase 2
- Treatment of Multiple Sclerosis With Copaxone and AlbuterolCompletedNCT00039988Not applicable
- Auditory Function in Patients With and Without Multiple SclerosisCompletedNCT00037947Phase 2
- Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.WithdrawnNCT00037115Phase 4
- Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple SclerosisCompletedNCT00037102Phase 4
- A Study to Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-remitting Multiple SclerosisTerminatedNCT00035529Phase 2
- Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple SclerosisCompletedNCT00030966Phase 3
- Safety and Efficacy of Natalizumab in the Treatment of Multiple SclerosisCompletedNCT00027300Phase 3
- Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple SclerosisCompletedNCT00017628Phase 1
- Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple SclerosisCompletedNCT00014755Phase 1
- Rolipram to Treat Multiple SclerosisCompletedNCT00011375Phase 2
- Yoga: Effect on Attention in Aging & Multiple SclerosisCompletedNCT00010998Phase 2
- Natural Antioxidants in the Treatment of Multiple SclerosisCompletedNCT00010842Phase 1/2
- Diagnostic Study of Quantitative Imaging and Spectroscopy in Patients With Multiple SclerosisStatus unknownNCT00006060
- A Maintenance Extension of Phase I Pilot Study of Chimeric Anti-CD4 Antibody M-T412 in Patients With Multiple SclerosisCompletedNCT00004816Phase 1
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple SclerosisCompletedNCT00004814Phase 3
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple SclerosisCompletedNCT00004744Phase 3
- Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous MethylprednisoloneStatus unknownNCT00004645Phase 3
- Zenapax to Treat Multiple SclerosisCompletedNCT00001934Phase 2
- Safety, Tolerability, and Effectiveness of CGP77116 in Patients With Multiple Sclerosis (MS)CompletedNCT00001781Phase 2
- A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) PatientsCompletedNCT00001669Phase 2
- Assessment of Patients With Multiple Sclerosis (MS)CompletedNCT00001156
- Longitudinal Optic Neuritis Study (LONS)Status unknownNCT00000147Not applicable
- Optic Neuritis Treatment Trial (ONTT)Status unknownNCT00000146Phase 3